Cargando…
Neonatal Gene Therapy for Hemophilia B by a Novel Adenovirus Vector Showing Reduced Leaky Expression of Viral Genes
Gene therapy during neonatal and infant stages is a promising approach for hemophilia B, a congenital disorder caused by deficiency of blood coagulation factor IX (FIX). An adenovirus (Ad) vector has high potential for use in neonatal or infant gene therapy for hemophilia B due to its superior trans...
Autores principales: | Iizuka, Shunsuke, Sakurai, Fuminori, Tachibana, Masashi, Ohashi, Kazuo, Mizuguchi, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552065/ https://www.ncbi.nlm.nih.gov/pubmed/28828393 http://dx.doi.org/10.1016/j.omtm.2017.07.001 |
Ejemplares similares
-
Evaluation of Transduction Properties of an Adenovirus Vector in Neonatal Mice
por: Iizuka, Shunsuke, et al.
Publicado: (2015) -
Suppression of leaky expression of adenovirus genes by insertion of microRNA-targeted sequences in the replication-incompetent adenovirus vector genome
por: Shimizu, Kahori, et al.
Publicado: (2014) -
Adenovirus vector-based vaccine for infectious diseases
por: Sakurai, Fuminori, et al.
Publicado: (2022) -
NF-κB promotes leaky expression of adenovirus genes in a replication-incompetent adenovirus vector
por: Machitani, M., et al.
Publicado: (2016) -
Antibodies against adenovirus fiber and penton base proteins inhibit adenovirus vector-mediated transduction in the liver following systemic administration
por: Tomita, Kyoko, et al.
Publicado: (2018)